<html>
 <body>
  <div class="col-md-12" id="content" style="">
   <div class="hidden" data-drupal-messages-fallback="">
   </div>
   <div class="widget block" id="block-medsites-page-title">
    <h1>
     <span property="schema:name">
      Lymphoma
     </span>
    </h1>
   </div>
   <div class="widget block" id="block-medsites-content">
    <article about="/commodorecompendium/lymphoma" data-history-node-id="1030" role="article" typeof="schema:WebPage">
     <div>
      <div class="field field--name-body field--type-text-with-summary field--label-hidden field__item" property="schema:text">
       <div class="WordSection1">
        <div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
         <p style="border:none; padding:0in">
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <b>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Lymphoma - Margaret Wheless
                </span>
               </span>
              </b>
             </span>
            </span>
           </span>
          </span>
         </p>
        </div>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Background
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Malignancy of lymphoid cells comprising multiple different cancers of the immune system depending on the subtype and stage of development of cell/tissue involved
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Characterized by lymphadenopathy & constitutional “B” symptoms:
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Fevers, drenching night sweats and weight loss
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Branch point of diagnosis:
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Hodgkin: 10% - superficial, nodal disease with orderly spread
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Non
                   </span>
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    -Hodgkin: 90% - diffuse, nodal and extranodal disease with noncontiguous spread
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
        </ul>
        <p style="border:none; margin-left:1px">
        </p>
        <p style="border:none; margin-left:1px">
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               <span style="color:black">
                Evaluation
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 B symptoms; pruritus (10-15% of pt with HL); history of radiation
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Lymphadenopathy: painless, firm, fixed, >1cm
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Exam: head & neck, tonsils, axilla, testes, liver, spleen
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 CBC, CMP, LDH, Uric Acid
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 HBV, HCV,  HIV, EBV, Quant gold, Treponemal Ab, ANA
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Imaging: CXR
                </span>
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style="font-family:Wingdings">
                <span style="color:black">
                 
                </span>
               </span>
              </span>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 most will eventually need PET-CT; MRI brain if neuro symptoms
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Diagnosis requires tissue
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Excisional
                   </span>
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Lymph node biopsy (surg onc. Consult)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Core biopsy (CT guided procedure consult)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Ann Arbor Staging System: I. 1 LN region
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    II. >2 LN regions, same side of diaphragm
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    III. LN regions on both sides of diaphragm
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    IV. Dissem dz w/ 1+ extralymphatic organ
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
        </ul>
        <p>
        </p>
        <div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
         <p style="border:none; padding:0in">
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:107%">
             <span style="font-family:Calibri,sans-serif">
              <b>
               <span style="font-size:12.0pt">
                <span style="line-height:107%">
                 <span style="font-family:Palatino">
                  Non-Hodgkin Lymphoma (NHL)
                 </span>
                </span>
               </span>
              </b>
             </span>
            </span>
           </span>
          </span>
         </p>
        </div>
        <p style="border:none">
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               <span style="color:black">
                Background
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 65 y/o, M>F, 85-90% B-cell
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Associated with immunodeficiency (HIV, post-transplant), autoimmune disease (both the disease and immunosuppression), infection (EBV, HTLV-1, H pylori,  HCV, Borrelia, C
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 psittacosis, Coxiella)
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Stratify into:
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   Good prognosis
                  </span>
                 </span>
                 <b>
                  <span style="font-size:12.0pt">
                   <span style="font-family:Palatino">
                    :
                   </span>
                  </span>
                 </b>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   waxing/waning LAD, cytopenias, hepatomegaly or splenomegaly
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Poor
                   </span>
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    prognosis
                   </span>
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    : Aggressive presentation: fever, night sweats, weight loss, TLS
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
        </ul>
        <p>
        </p>
        <table class="TableGrid3" style="width:100.0%; border-collapse:collapse; border:none" width="100%">
         <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>0</th>
      <th>1</th>
      <th>2</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Good Prognosis</td>
      <td>Good Prognosis</td>
      <td>Good Prognosis</td>
    </tr>
    <tr>
      <td>Diagnosis</td>
      <td>Key Features</td>
      <td>Workup/Treatment</td>
    </tr>
    <tr>
      <td>Follicular Lymphoma</td>
      <td>20-30% of NHL  T (14; 18) bcl-2 over expression; CD19+, 20+, 10+, CD5-, CD23-  Grading based on # large cells 1: &lt;25%, 2: 25-50%, 3. &gt;50% (grade 3= closer to DLBCL)</td>
      <td>Watchful waiting Treatment: bulky LAD symptomatic disease End-organ damage Cytopenia’s Excision or radiation (stage I) Bendamustine-R (B-R) or RCHOP (&gt; I)</td>
    </tr>
    <tr>
      <td>Marginal Zone Lymphoma</td>
      <td>Usually located in the GI, thyroid, orbit, lung, breast, salivary glands</td>
      <td>Treatment: Treat H pylori if MALT Treat HCV if splenic Extranodal MALT: B-R, rituximab x 4 doses</td>
    </tr>
    <tr>
      <td>Mycosis Fungoides  Sezary syndrome</td>
      <td>Skin plaques with atypical CD4+ cells  May progress to Sezary syndrome aka T cell leukemia</td>
      <td>Workup: Skin biopsy  Treatment: Light therapy, topical steroids, superficial radiation</td>
    </tr>
  </tbody>
</table>
        </table>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <b>
             </b>
            </span>
           </span>
          </span>
         </span>
        </p>
       </div>
       <p>
       </p>
       <div class="WordSection2">
        <table class="TableGrid3" style="width:348px; border-collapse:collapse; border:none" width="348">
         <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>0</th>
      <th>1</th>
      <th>2</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>NaN</td>
      <td>Aggressive/Poor Prognosis</td>
      <td>NaN</td>
    </tr>
    <tr>
      <td>Diagnosis</td>
      <td>Key Features</td>
      <td>Workup/Treatment</td>
    </tr>
    <tr>
      <td>DLBCL</td>
      <td>~25% of NHL; CD20+, CD45+ CD5+ confers the worst prognosis Can arise as transformation from low- grade lymphoma (Richter’s transformation) 60% present with advanced disease Risk factors for CNS disease: involvement of testicle, paranasal sinus, epidural space, bone marrow or &gt;1 extra nodal sites + ↑LDH CNS disease needs IT and systemic MTX</td>
      <td>If PET/CT reveals BM disease then no need for biopsy  Tx: RCHOP vs DA-R-EPOCH (double hit) Use IPI prognostic scoring</td>
    </tr>
    <tr>
      <td>Mantle Cell Lymphoma</td>
      <td>7% NHL; CD20+, CD200+ T(11;14) =↑Cyclin D1 M&gt;F; avg age ~50-60s Most present with diffuse disease Blastoid variant more often involves CNS</td>
      <td>Dx: pathology from bx Use MIPI prognostic tool Treatment: Aggressive: R-hyperCVAD-M/ara-C Poor PS: BR &amp; Rituximab</td>
    </tr>
    <tr>
      <td>Double or Triple Hit Lymphoma</td>
      <td>Similar to DLBCL with combination of bcl-2, bcl-6, or myc aberrations conveying double or triple hits  Very aggressive needs intrathecal ppx even if no evidence of CNS disease</td>
      <td>PET/CT for staging; if no evidence of BM involvement on PET, will need biopsy Tx: Da-R-EPOCH vs R hyperCVAD/MA vs R-CODOX-M/ IVAC</td>
    </tr>
    <tr>
      <td>Burkitt Lymphoma</td>
      <td>MYC translocation - most commonly t (8;14) with path showing classic “starry-sky” Rapidly growing tumors HIV: CNS relapse is 30-50% if no CNS ppx  1. Endemic (African jaw); often EBV/CD21+ 2. Sporadic (in the US): median age 30 at dx; present w/ abdominal masses &amp; metastasis 3. Immunodeficiency-related (often seen with CD4 counts &gt;200); more often involve LN, CNS, and BM</td>
      <td>R-EPOCH vs R-CODOX-M/IVAC Everyone gets CNS prophylaxis  TLS prophylaxis for all pts  Everyone will need TTE before anthracycline-based chemo</td>
    </tr>
    <tr>
      <td>Lymphoblastic Lymphoma</td>
      <td>Express TdT+ (cyclin D1 -) Aggressive; often present with mediastinal mass and CNS involvement Consider empiric allopurinol before starting chemotherapy</td>
      <td>Treated like acute leukemias Will need LP with IT chemo</td>
    </tr>
    <tr>
      <td>Anaplastic Large Cell Lymphoma (ALCL)</td>
      <td>&lt; 2% of NHL Primary cutaneous variant can arise from existing mycosis fungoides  Worse outcome predictor includes increased β-2 microglobulin &gt;3 and age &gt;40</td>
      <td>Use IPI prognostic tool Treatment: check CD30 +/- status - CD30+: BV(brentuximab)+ CHP (cyclophosphamide, doxorubicin, prednisone) CD30-: CHOP + etoposide</td>
    </tr>
  </tbody>
</table>
        </table>
        <p>
        </p>
        <p>
        </p>
       </div>
       <p>
       </p>
       <div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
        <p style="border:none; padding:0in">
         <span style="font-size:11pt">
          <span style="line-height:107%">
           <span style="font-family:Calibri,sans-serif">
            <b>
             <span style="font-size:12.0pt">
              <span style="line-height:107%">
               <span style="font-family:Palatino">
                Hodgkin Lymphoma (HL)
               </span>
              </span>
             </span>
            </b>
           </span>
          </span>
         </span>
        </p>
       </div>
       <p style="border:none">
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             <span style="color:black">
              Background
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               Bimodal Distritbution: 15-35 y/o and >50; M>F
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               CD15+, CD30+ (Reed Sternberg cells “owl eyes”)
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               Associated with EBV in immunocompromised pt
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               4 classical types
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
         <ul style="list-style-type:circle">
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="tab-stops:9.0pt">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Nodular sclerosing (60-80%): young adult, F>M, low stage, mediastinal LAD, collagen bands
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="tab-stops:9.0pt">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Lymphocyte rich (5%): best prog
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="tab-stops:9.0pt">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Lymphocyte depleted (<1%): worst prognosis, older, M>F, disseminated, HIV+, diffuse positive and RS cells
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="tab-stops:9.0pt">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Mixed (15-30%): older, M>F, intermediate prognosis
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
         </ul>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               1 nonclassical (5%): nodular lymphocyte predominant, peripheral LN
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p style="border:none">
       </p>
       <p style="border:none">
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             <span style="color:black">
              Presentation
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               Lymphadenopathy (usually contiguous), generalized pruritus, Incidental mediastinal mass
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               B-Symptoms: fevers, night sweats, weight loss
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p style="border:none">
       </p>
       <p style="border:none">
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             <span style="color:black">
              Evaluation
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               IPS negative prognostic calculator: albumin <4, hemoglobin <10.5, male, stage IV by Ann Arbor, age>45, WBC count> 15K, lymphocyte <8%
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p style="border:none">
       </p>
       <p style="border:none">
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             <span style="color:black">
              Management
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               Stage I-II: ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) ± RT
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               Stages III-IV: ABVD x6 or escalated BEACOPP (bleo, etop, doxo, cyclophos, vinc, procarbazine, prednisone)
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p style="border:none; margin-right:8px">
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             <span style="color:black">
              Additional Information
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               Pts will need TTE prior to chemo given the use of anthracycline
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               Increased risk of secondary cancers (~25% of pt with 40% increased risk over next 40 years)
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
      </div>
     </div>
    </article>
   </div>
  </div>
 </body>
</html>